Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Conditions:   Malignant Pleural Mesotheliomas (Mpm);   Malignant Pleural Effusions (Mpe);   Epithelial Tumors, Malignant;   Pleural Effusions, Malignant;   Mesothelin (Msln) Interventions:   Procedure: Cytoreductive surgery;   Drug: LMB-100;   Diagnostic Test: Immunohistochemical Assay for Mesothelin Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials